Home Tags NTLA
Why Intellia Therapeutics is Up $4 Today
Keep an eye on Intellia Therapeutics (NTLA). Tomorrow, the company will present interim clinical data from its ongoing first-in-human studies of NTLA-2002 and NTLA-2001 for...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.